~~<i id='A5AEAFF74A'><strike id='A5AEAFF74A'><tt id='A5AEAFF74A'><pre id='A5AEAFF74A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：comprehensive 2025-10-02 00:43:07 - browse：3454

Three sales executives, all of them women, have filed suit against Grail, a cancer diagnostics company, alleging that they were harassed, that the company failed to take corrective action, and that it retaliated by removing them from consideration for promotions.

The suits, which were filed earlier this week, are complicated by the fact that Grail was purchased by Illumina, the largest DNA sequencing firm, for $8 billion in 2021 — yet Illumina has left Grail to operate as a separate company. Illumina is named in the suit.

All three plaintiffs are being represented by the Vora Law Firm, based in Santa Monica, Calif.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

hotspot

Wikipedia

focus

hotspot

focus

ChristineKao/STATTheFoodandDrugAdministration’sapprovalonFridayoftwogenetherapiesforsicklecelldiseas

WSS

Pregnancy discrimination could be enabled by AI

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

Pfizer plans to depart BIO

Supreme Court wrestles with OxyContin maker's bankruptcy deal

The woman behind the Dana Farber

Pregnancy discrimination could be enabled by AI

entertainment

entertainment

hotspot

In age of alternative facts, a scholarly course on calling out crap

Removing probiotics from the NICU could threaten preemies' health

Malaria cases in Florida and Texas: Here’s what you need to know

Why sickle cell disease is getting the first CRISPR treatment

Drug repurposing or repositioning? The language matters

Pregnancy discrimination could be enabled by AI

Malaria cases in Florida and Texas: Here’s what you need to know

FDA needs staff influx to meet gene therapy needs, Marks says

Novavax promises a turnaround & Lilly roils the obesity market

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Wikipedia

Senate panel clears PBM, hopsital reforms

A clever new way to fix Medicaid and graduate medical education

White House calls on federal agencies to crack down on AI abuses

UCSF medical school apologizes for unethical prisoner experiments

Study: New antibiotic targets gonorrhea as well as last existing drug

Chemotherapy shortages won’t get better under Biden’s latest plan

focus

hotspot

focus

focus